A small study published today in the journal Critical Care, reveals that most Intensive Care Unit (ICU) patients who gave their informed consent to take part in a clinical trial remembered having participated in the trial ten days later. But two-thirds of the patients did not remember the purpose and risks of the trial, although they had been given information about them before the trial started.
Catherine Chenaud and colleagues from the University Hospital of Geneva, Switzerland, studied 44 ICU patients who had been selected for a clinical trial on inflammatory responses. The patients were given a 20-minute presentation about the study, its purpose and its risks and were given a leaflet to read, before agreeing to participate in the trial. They were then interviewed ten days later.
Chenaud et al.’ s results show that 35/44 patients remembered having taken part in the trial, but that only 20/44 patients remembered the purpose of the study and only 21/44 patients remembered the study risks. Furthermore, only 14/44 patients remembered both the purpose of the trial and its associated risks. The 14 patients who remembered all aspects of the trial did not differ from other patients, except that they had read the leaflet or had asked at least one question during the presentation, before signing the consent form.
The authors conclude that obtaining informed consent from patients should be a process which is revisited many times, rather than one event at the start of the trial, and that patients should be given information repeatedly during the course of a trial.
Juliette Savin | alfa
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy